[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341773-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341773-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploring-cell-derived-extracellular-vesicles-in-peripheral-blood-and-bone-marrow-of-b-cell-acute-lymphoblastic-leukemia-pediatric-patients-proof-of-concept-study","Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients - proof-of-concept study","","Extracellular vesicles (EVs) are heterogeneous phospholipid membrane particles secreted by healthy and cancer cells and linked to disease severity, making them promising biomarkers and therapeutic targets. This proof-of-concept study characterizes EVs derived from peripheral blood and bone marrow in pediatric B-cell acute lymphoblastic leukemia (B-ALL) across induction therapy stages. EVs were profiled at diagnosis baseline (D0), day 15 (D15), and end of induction therapy (D35), using flow cytometry with defined cellular markers and ROC analysis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploring-cell-derived-extracellular-vesicles-in-peripheral-blood-and-bone-marrow-of-b-cell-acute-lymphoblastic-leukemia-pediatric-patients-proof-of-concept-study/341773/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploring-cell-derived-extracellular-vesicles-in-peripheral-blood-and-bone-marrow-of-b-cell-acute-lymphoblastic-leukemia-pediatric-patients-proof-of-concept-study/341773.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study?","Question",{"text":63,"@type":64},"To investigate the phenotypic characteristics of cell-derived extracellular vesicles in peripheral blood and bone marrow of pediatric B-cell acute lymphoblastic leukemia patients across treatment stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which treatment time points were used for EV analysis?",{"text":68,"@type":64},"Samples were collected at diagnosis baseline (D0), day 15 of induction therapy (D15), and the end of induction therapy (D35).",{"name":70,"@type":61,"acceptedAnswer":71},"How did the study assess diagnostic biomarker potential?",{"text":72,"@type":64},"It used fold-change evaluation and receiver operating characteristic (ROC) curve analysis to identify EV marker signatures associated with B-ALL.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341773,1790863221,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 21 August 2024  \nDOI 10.3389/fimmu.2024.1421036  \nOPEN ACCESS  \nEDITED BY  \nPaulo Rodrigues-Santos, University of Coimbra, Portugal  \nREVIEWED BY  \nMauro Di Ianni,  \nUniversity of Studies G. d’Annunzio Chieti and Pescara, Italy  \nOlga Janouskova,  \nJan Evangelista Purkynˇe University in U´st nad Labem, Czechia  \n*CORRESPONDENCE Allyson Guimarães Costa  \n [allyson.gui.costa@gmail.com](allyson.gui.costa@gmail.com)[ ](allyson.gui.costa@gmail.com)†These authors share senior authorship  \nRECEIVED 21 April 2024  \nACCEPTED 25 July 2024  \nPUBLISHED 21 August 2024  \nCITATION  \nMagalhães-Gama F,  \nMalheiros Arau´ jo Silvestrini M, Neves JCF, Arau´ jo ND, Alves-Hanna FS, Kerr MWA, Carvalho MPSS, Tarragˆo AM, Soares Pontes G, Martins-Filho OA, Malheiro A,  \nTeixeira-Carvalho A and Costa AG (2024) Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study.  \nFront. Immunol. 15:1421036 .  \ndoi: 10.3389/fimmu.2024.1421036  \nCOPYRIGHT  \n© 2024 Magalhães-Gama,  \nMalheiros Arau´jo Silvestrini, Neves, Arau´jo, Alves-Hanna, Kerr, Carvalho, Tarragˆo,  \nSoares Pontes, Martins-Filho, Malheiro, Teixeira-Carvalho and Costa. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study  \nF´abio Magalhães-Gama 1,2,3,4,  \nMarina Malheiros Ara ´ujo Silvestrini 3,4,  \nJuliana Costa Ferreira Neves 2,5, Nilberto Dias Ara ´ujo 1,2,6, Fab ´ıola Silva Alves-Hanna 1,2, Marlon Wendell Athaydes Kerr 2,6, Maria Perp´etuo Socorro Sampaio Carvalho 2,6,  \nAndr´ea Monteiro Tarragˆo2,6, Gemilson Soares Pontes 1,6,7, Olindo Assis Martins-Filho 3,4,6, Adriana Malheiro 1,2,6,  \nAndr´ea Teixeira-Carvalho 3,4,6† and Allyson Guimarães Costa 1,2,6*†  \n1 Programa de Po´s-graduaão em Imunologia B´asica e Aplicada, Instituto de Ciˆencias Biolo´gicas, Universidade Federal do Amazonas (UFAM), Manaus, Brazil, 2 Diretoria de Ensino e Pesquisa, Fundaão Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), Manaus, Brazil, 3 Programa de Po´s-graduaão em Ciˆencias da Sau´ de, Instituto Rene´ Rachou-Fundaão Oswaldo Cruz (FIOCRUZ) Minas, Belo Horizonte, Brazil, 4Grupo Integrado de Pesquisas em Biomarcadores, Belo  \nHorizonte, Brazil, 5 Programa de Po´s-graduaão em Medicina Tropical, Universidade do Estado do Amazonas (UEA), Manaus, Brazil, 6 Programa de Po´s-graduaão em Ciˆencias Aplicadas à Hematologia, UEA, Manaus, Brazil, 7 Laborato´rio de Virologia e Imunologia, Instituto Nacional de Pesquisas da Amazˆonia (INPA), Manaus, Brazil  \nExtracellular vesicles (EVs) are heterogeneous, phospholipid membrane enclosed particles that are secreted by healthy and cancerous cells. EVs are present in diverse biological ﬂuids and have been associated with the severity of diseases, which indicates their potential as biomarkers for diagnosis, prognosis and as therapeutic targets. This study investigated the phenotypic characteristics of EVs derived from peripheral blood (PB) and bone marrow (BM) in pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL) during different treatment stages. PB and BM plasma were collected from 20 B-ALL patients at three time points during induction therapy, referred to as: diagnosis baseline (D0), day 15 of induction therapy (D15) and the end of the induction therapy (D35) . In addition, PB samples were collected from 10 healthy children at a single  \nAbbreviations: ADAM17, A","cbCaipkFD0JSYtx8","https://ap.wps.com/l/cbCaipkFD0JSYtx8","pdf",11206038,16,"English","# Study aim and rationale\n## Patient cohorts and sampling time points\n## EV measurement and marker labeling\n## Results: EV production kinetics and biological profiles\n## Diagnostic potential and conclusions","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To investigate the phenotypic characteristics of cell-derived extracellular vesicles in peripheral blood and bone marrow of pediatric B-cell acute lymphoblastic leukemia patients across treatment stages.\"},{\"question\":\"Which treatment time points were used for EV analysis?\",\"answer\":\"Samples were collected at diagnosis baseline (D0), day 15 of induction therapy (D15), and the end of induction therapy (D35).\"},{\"question\":\"How did the study assess diagnostic biomarker potential?\",\"answer\":\"It used fold-change evaluation and receiver operating characteristic (ROC) curve analysis to identify EV marker signatures associated with B-ALL.\"}]","Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients - proof-of-concept study | PDF",1790043736,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c7a7e7c7588ce0238212a2657caf369.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6eef58dda1ac13a8ebd1c35e7865a7b.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff5e505dbf1ca184858e768f69b22590.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c0a869ac466287b18d725c6d6979945.webp",980,1385]